10-QPeriod: Q3 FY2024

CHURCH & DWIGHT CO INC /DE/ Quarterly Report for Q3 Ended Sep 30, 2024

Filed November 1, 2024For Securities:CHD

Summary

Church & Dwight Co., Inc. (CHD) reported a net loss of $75.1 million for the third quarter of 2024, a significant shift from the $177.5 million net income in the prior year. This downturn was primarily driven by a substantial $357.1 million non-cash impairment charge related to the Vitamins, Minerals, and Supplements (VMS) business, impacting goodwill and other intangible assets. Despite this, the company saw a 3.8% increase in net sales to $1,510.6 million, with growth in both the Consumer Domestic and Consumer International segments, indicating underlying demand for its core products. Operationally, the company managed to improve its gross margin by 80 basis points to 45.2% due to productivity gains and favorable pricing, partially offset by higher manufacturing costs. Marketing expenses increased to support new product introductions. The company maintained a strong liquidity position with $752.1 million in cash and cash equivalents and significant availability under its revolving credit facility. The impairment charge significantly impacted operating income and EPS, resulting in a diluted loss per share of $0.31 for the quarter. Management is focusing on integrating recent acquisitions and managing costs while navigating a competitive market landscape.

Financial Highlights

56 data points
Beta

Revenue

$1.51B

45.2% Gross Margin

Net Income

-$75.10M

-5.0% Net Margin

EPS (Diluted)

$-0.31

Total Assets

$8.67B

Cash & Equivalents

$752.10M

Free Cash Flow

$315.40M

Financial Statements
Beta
Revenue$1.51B
Cost of Revenue$827.50M
Gross Profit$683.10M
R&D Expenses$36.00M
SG&A Expenses$231.70M
Operating Income-$91.50M
Interest Expense$23.40M
Net Income-$75.10M
EPS (Basic)$-0.31
EPS (Diluted)$-0.31
Shares Outstanding (Basic)244.60M
Shares Outstanding (Diluted)244.60M

Key Highlights

  • 1Third-quarter net loss of $75.1 million due to a $357.1 million impairment charge on VMS assets, contrasting with a $177.5 million profit in Q3 2023.
  • 2Net sales increased by 3.8% to $1,510.6 million in the third quarter, driven by volume and favorable pricing/mix across segments.
  • 3Gross margin improved by 80 basis points to 45.2% due to productivity initiatives and price/volume/mix, despite higher manufacturing costs.
  • 4Marketing expenses rose 10.7% to support new product launches, impacting operating expenses.
  • 5The company acquired Graphico for $19.9 million, expanding its presence in the Asia-Pacific region.
  • 6Liquidity remains strong with $752.1 million in cash and cash equivalents and substantial credit facility availability.
  • 7Diluted EPS turned negative at $(0.31) for the quarter, primarily due to the significant impairment charge.

Frequently Asked Questions

The net loss of $75.1 million was primarily caused by a substantial $357.1 million non-cash impairment charge recognized in the third quarter. This charge related to the decline in market share and financial performance of the Vitamins, Minerals, and Supplements (VMS) business, impacting intangible assets like trade names and customer relationships, as well as related property, plant, and equipment.

Excluding the impact of the impairment charge, the company's sales showed resilience. Net sales increased by 3.8% to $1,510.6 million, driven by a 3.1% increase in product volumes and a 1.2% favorable impact from pricing and product mix. Growth was observed in both the Consumer Domestic and Consumer International segments.

The impairment charge reflects a reassessment of the long-term strategy and financial outlook for the VMS business due to significant competition and declining market share. The revised outlook indicates lower estimated future sales growth and cash flows, suggesting continued challenges for this segment. Management is focused on growth and profitability initiatives, but the impairment highlights a significant underperformance.

The company maintains a strong liquidity position with $752.1 million in cash and cash equivalents as of September 30, 2024. It also has approximately $1,495.0 million available under its revolving credit facility and commercial paper program. Debt levels have decreased due to the repayment of a $200.0 million term loan in the first quarter of 2024, and the company anticipates sufficient cash from operations and borrowing capacity to meet its financial obligations, including dividends and capital expenditures.